Mitroaortic valve replacement after aortic transapical approach failure in a patient with essential thrombocytosis

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There is a lack of published information about intraoperative and postoperative course of cardiac surgery in patients with essential thrombocytosis using cardiopulmonary bypass. Both risks of intraoperative thrombosis of extracorporeal conduits or uncontrolled postoperative bleeding are present, but its incidence and treatment are not well known. Here, we present a rare case of a patient with essential thrombocytosis, moderate mitral regurgitation and severe aortic stenosis who had a transapical aortic valve implantation with short-term severe periprosthetic regurgitation, who needed a mitroaortic replacement on cardiopulmonary bypass with no complications. © 2010 Published by European Association for Cardio-Thoracic Surgery.

Cite

CITATION STYLE

APA

Gutierrez-Martin, M. A., Araji, O. A., Miranda, N., & Barquero, J. M. (2010). Mitroaortic valve replacement after aortic transapical approach failure in a patient with essential thrombocytosis. Interactive Cardiovascular and Thoracic Surgery, 11(3), 360–361. https://doi.org/10.1510/icvts.2010.240135

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free